Skip to main content
Livermore
Livermore
ZHEN

Redmile Group, LLC

SEC CIK
0001425738
Latest filing
Aug 14, 2026

BEAM holding history

Beam Therapeutics Inc. in every 13F filed by Redmile Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BEAM overviewAll 13F holders of BEAMFull Q2 2026 holdings

Shares (Q2 2026)
1,164,259
Value
$40.0M
% of portfolio
2.7%
Quarters held
22
Since Q1 2021
Holdings of BEAM by Redmile Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,164,259$40.0M2.7%−73,400−5.9%ReducedHolders
Q1 20261,237,659$29.5M2.0%−48,200−3.7%ReducedHolders
Q4 20251,285,859$35.6M2.6%−101,700−7.3%ReducedHolders
Q3 20251,387,559$33.7M3.3%−35,852−2.5%ReducedHolders
Q2 20251,423,411$24.2M2.6%−186,918−11.6%ReducedHolders
Q1 20251,610,329$31.4M3.0%+81,762+5.3%AddedHolders
Q4 20241,528,567$37.9M2.6%−82,446−5.1%ReducedHolders
Q3 20241,611,013$39.5M2.3%−92,048−5.4%ReducedHolders
Q2 20241,703,061$39.9M2.4%−176,556−9.4%ReducedHolders
Q1 20241,879,617$62.1M2.3%+449,834+31.5%AddedHolders
Q4 20231,429,783$38.9M1.4%−39,942−2.7%ReducedHolders
Q3 20231,469,725$35.3M1.7%−15,474−1.0%ReducedHolders
Q2 20231,485,199$47.4M1.8%−126,895−7.9%ReducedHolders
Q1 20231,612,094$49.4M2.1%−158,493−9.0%ReducedHolders
Q4 20221,770,587$69.2M2.8%−2,400−0.1%ReducedHolders
Q3 20221,772,987$84.5M3.3%−76,900−4.2%ReducedHolders
Q2 20221,849,887$71.6M2.7%+13,837+0.8%AddedHolders
Q1 20221,836,050$105.2M3.3%−49,800−2.6%ReducedHolders
Q4 20211,885,850$150.3M3.4%−89,156−4.5%ReducedHolders
Q3 20211,975,006$171.8M3.0%−77,500−3.8%ReducedHolders
Q2 20212,052,506$264.2M3.9%−480,017−19.0%ReducedHolders
Q1 20212,532,523$202.7M2.9%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.